chr2-147917228-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001616.5(ACVR2A):c.673-55G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,541,212 control chromosomes in the GnomAD database, including 72,097 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5956 hom., cov: 32)
Exomes 𝑓: 0.30 ( 66141 hom. )
Consequence
ACVR2A
NM_001616.5 intron
NM_001616.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.548
Publications
10 publications found
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACVR2A | NM_001616.5 | c.673-55G>C | intron_variant | Intron 5 of 10 | ENST00000241416.12 | NP_001607.1 | ||
| ACVR2A | NM_001278579.2 | c.673-55G>C | intron_variant | Intron 6 of 11 | NP_001265508.1 | |||
| ACVR2A | NM_001278580.2 | c.349-55G>C | intron_variant | Intron 5 of 10 | NP_001265509.1 | |||
| ACVR2A | XM_047446292.1 | c.349-55G>C | intron_variant | Intron 5 of 10 | XP_047302248.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACVR2A | ENST00000241416.12 | c.673-55G>C | intron_variant | Intron 5 of 10 | 1 | NM_001616.5 | ENSP00000241416.7 | |||
| ACVR2A | ENST00000404590.1 | c.673-55G>C | intron_variant | Intron 6 of 11 | 1 | ENSP00000384338.1 | ||||
| ACVR2A | ENST00000535787.5 | c.349-55G>C | intron_variant | Intron 5 of 10 | 2 | ENSP00000439988.1 |
Frequencies
GnomAD3 genomes AF: 0.260 AC: 39455AN: 151606Hom.: 5960 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39455
AN:
151606
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.304 AC: 422771AN: 1389488Hom.: 66141 AF XY: 0.304 AC XY: 208763AN XY: 687032 show subpopulations
GnomAD4 exome
AF:
AC:
422771
AN:
1389488
Hom.:
AF XY:
AC XY:
208763
AN XY:
687032
show subpopulations
African (AFR)
AF:
AC:
3037
AN:
30748
American (AMR)
AF:
AC:
13509
AN:
36318
Ashkenazi Jewish (ASJ)
AF:
AC:
8003
AN:
24422
East Asian (EAS)
AF:
AC:
17013
AN:
37576
South Asian (SAS)
AF:
AC:
22933
AN:
77490
European-Finnish (FIN)
AF:
AC:
17484
AN:
52356
Middle Eastern (MID)
AF:
AC:
2202
AN:
5438
European-Non Finnish (NFE)
AF:
AC:
321364
AN:
1067758
Other (OTH)
AF:
AC:
17226
AN:
57382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
13841
27683
41524
55366
69207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10704
21408
32112
42816
53520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.260 AC: 39468AN: 151724Hom.: 5956 Cov.: 32 AF XY: 0.263 AC XY: 19487AN XY: 74120 show subpopulations
GnomAD4 genome
AF:
AC:
39468
AN:
151724
Hom.:
Cov.:
32
AF XY:
AC XY:
19487
AN XY:
74120
show subpopulations
African (AFR)
AF:
AC:
4444
AN:
41462
American (AMR)
AF:
AC:
4706
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
AC:
1093
AN:
3462
East Asian (EAS)
AF:
AC:
2393
AN:
5172
South Asian (SAS)
AF:
AC:
1399
AN:
4814
European-Finnish (FIN)
AF:
AC:
3530
AN:
10556
Middle Eastern (MID)
AF:
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20919
AN:
67752
Other (OTH)
AF:
AC:
622
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1439
2877
4316
5754
7193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1067
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.